Buy Or Sell Opportunity • May 04
Now 23% overvalued after recent price rise Over the last 90 days, the stock has risen 31% to zł0.46. The fair value is estimated to be zł0.37, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company became loss making. Buy Or Sell Opportunity • Mar 31
Now 23% overvalued after recent price rise Over the last 90 days, the stock has risen 23% to zł0.49. The fair value is estimated to be zł0.40, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company became loss making. Buy Or Sell Opportunity • Mar 16
Now 30% overvalued after recent price rise Over the last 90 days, the stock has risen 36% to zł0.52. The fair value is estimated to be zł0.40, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company became loss making. Buy Or Sell Opportunity • Feb 24
Now 25% overvalued after recent price rise Over the last 90 days, the stock has risen 21% to zł0.50. The fair value is estimated to be zł0.40, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company became loss making. Reported Earnings • Feb 21
Full year 2025 earnings released: zł0.007 loss per share (vs zł0 in FY 2024) Full year 2025 results: zł0.007 loss per share (further deteriorated from zł0 in FY 2024). Revenue: zł15.1m (down 3.3% from FY 2024). Net loss: zł99.0k (down zł101.8k from profit in FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 76 percentage points per year, which is a significant difference in performance. New Risk • Dec 03
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 16% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Earnings have declined by 14% per year over the past 5 years. Market cap is less than US$10m (zł5.70m market cap, or US$1.57m). Minor Risks Shareholders have been diluted in the past year (16% increase in shares outstanding). Revenue is less than US$5m (zł15m revenue, or US$4.2m). Duyuru • Nov 12
Maxipizza SA to Report Q3, 2025 Results on Nov 14, 2025 Maxipizza SA announced that they will report Q3, 2025 results on Nov 14, 2025 Reported Earnings • May 19
First quarter 2025 earnings released First quarter 2025 results: Revenue: zł3.64m (down 7.5% from 1Q 2024). Net loss: zł49.0k (down 209% from profit in 1Q 2024). Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings. Reported Earnings • Feb 20
Full year 2024 earnings released: EPS: zł0.004 (vs zł0.025 in FY 2023) Full year 2024 results: EPS: zł0.004 (down from zł0.025 in FY 2023). Revenue: zł15.7m (up 1.3% from FY 2023). Net income: zł50.6k (down 82% from FY 2023). Profit margin: 0.3% (down from 1.8% in FY 2023). Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings. Buy Or Sell Opportunity • Jan 07
Now 37% overvalued after recent price rise Over the last 90 days, the stock has risen 7.0% to zł0.43. The fair value is estimated to be zł0.31, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 8.0% over the last 3 years. Earnings per share has grown by 12%. Buy Or Sell Opportunity • Nov 22
Now 34% overvalued Over the last 90 days, the stock has fallen 18% to zł0.44. The fair value is estimated to be zł0.33, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 8.0% over the last 3 years. Earnings per share has grown by 20%. Buy Or Sell Opportunity • Oct 16
Now 30% overvalued Over the last 90 days, the stock has fallen 10% to zł0.48. The fair value is estimated to be zł0.37, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 8.2% over the last 3 years. Earnings per share has grown by 18%. Reported Earnings • Aug 19
Second quarter 2024 earnings released Second quarter 2024 results: Revenue: zł3.97m (up 1.9% from 2Q 2023). Net income: zł54.7k (down 32% from 2Q 2023). Profit margin: 1.4% (down from 2.1% in 2Q 2023). Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings. Duyuru • Jun 05
Maxipizza SA, Annual General Meeting, Jun 28, 2024 Maxipizza SA, Annual General Meeting, Jun 28, 2024. Reported Earnings • May 19
First quarter 2024 earnings released First quarter 2024 results: Revenue: zł3.93m (up 5.6% from 1Q 2023). Net income: zł45.0k (up zł85.3k from 1Q 2023). Profit margin: 1.1% (up from net loss in 1Q 2023). New Risk • Mar 13
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 5.0% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Earnings have declined by 6.9% per year over the past 5 years. Market cap is less than US$10m (zł7.46m market cap, or US$1.91m). Minor Risks Large one-off items impacting financial results. Shareholders have been diluted in the past year (5.0% increase in shares outstanding). Revenue is less than US$5m (zł15m revenue, or US$4.0m). Buy Or Sell Opportunity • Feb 23
Now 23% undervalued Over the last 90 days, the stock has risen 8.9% to zł0.49. The fair value is estimated to be zł0.63, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 8.1% over the last 3 years. Earnings per share has grown by 23%. Reported Earnings • Feb 12
Full year 2023 earnings released: EPS: zł0.038 (vs zł0.036 in FY 2022) Full year 2023 results: EPS: zł0.038 (up from zł0.036 in FY 2022). Revenue: zł15.5m (up 11% from FY 2022). Net income: zł422.9k (up 6.0% from FY 2022). Profit margin: 2.7% (down from 2.9% in FY 2022). Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has fallen by 17% per year, which means it is significantly lagging earnings. Reported Earnings • Nov 18
Third quarter 2023 earnings released Third quarter 2023 results: Revenue: zł3.85m (up 12% from 3Q 2022). Net loss: zł30.0k (down 118% from profit in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings. Reported Earnings • Aug 18
Second quarter 2023 earnings released: EPS: zł0.007 (vs zł0.008 loss in 2Q 2022) Second quarter 2023 results: EPS: zł0.007 (up from zł0.008 loss in 2Q 2022). Revenue: zł3.90m (up 18% from 2Q 2022). Net income: zł80.4k (up zł143.3k from 2Q 2022). Profit margin: 2.1% (up from net loss in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings. Duyuru • Jun 04
Maxipizza SA, Annual General Meeting, Jun 30, 2023 Maxipizza SA, Annual General Meeting, Jun 30, 2023, at 09:00 Central European Standard Time. Duyuru • Jun 02
Maxipizza SA, Annual General Meeting, Jun 28, 2022 Maxipizza SA, Annual General Meeting, Jun 28, 2022, at 11:00 Central European Standard Time. Reported Earnings • Feb 18
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Full year 2021 results: EPS: zł0.088 (up from zł0.01 in FY 2020). Revenue: zł13.1m (up 5.8% from FY 2020). Net income: zł717.7k (up zł616.1k from FY 2020). Profit margin: 5.5% (up from 0.8% in FY 2020). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 11% per year whereas the company’s share price has fallen by 15% per year. Reported Earnings • Nov 19
Third quarter 2021 earnings released The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: zł3.27m (up 5.5% from 3Q 2020). Net income: zł221.2k (up zł186.9k from 3Q 2020). Profit margin: 6.8% (up from 1.1% in 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 61% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings. Reported Earnings • Aug 21
Second quarter 2021 earnings released The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: zł3.23m (up 16% from 2Q 2020). Net income: zł135.5k (up zł158.6k from 2Q 2020). Profit margin: 4.2% (up from net loss in 2Q 2020). The move to profitability was driven by higher revenue. Reported Earnings • Feb 17
Full year 2020 earnings released: EPS zł0.017 (vs zł0.038 in FY 2019) The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: zł12.3m (down 4.1% from FY 2019). Net income: zł180.8k (down 53% from FY 2019). Profit margin: 1.5% (down from 3.0% in FY 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 55% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings. Is New 90 Day High Low • Feb 15
New 90-day high: zł0.90 The company is up 49% from its price of zł0.60 on 16 November 2020. The Polish market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Hospitality industry, which is up 35% over the same period. Is New 90 Day High Low • Jan 27
New 90-day high: zł0.86 The company is up 34% from its price of zł0.65 on 28 October 2020. The Polish market is up 24% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Hospitality industry, which is up 96% over the same period. Is New 90 Day High Low • Jan 05
New 90-day high: zł0.78 The company is up 28% from its price of zł0.61 on 07 October 2020. The Polish market is up 14% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Hospitality industry, which is up 54% over the same period. Is New 90 Day High Low • Sep 18
New 90-day high: zł0.79 The company is up 35% from its price of zł0.58 on 18 June 2020. The Polish market is down 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Hospitality industry, which is down 23% over the same period.